<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Parasit Vectors</journal-id>
      <journal-id journal-id-type="iso-abbrev">Parasit Vectors</journal-id>
      <journal-title-group>
        <journal-title>Parasites &amp; Vectors</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1756-3305</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25174279</article-id>
      <article-id pub-id-type="pmc">4155076</article-id>
      <article-id pub-id-type="publisher-id">1567</article-id>
      <article-id pub-id-type="doi">10.1186/1756-3305-7-401</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Short Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Contact dermatitis-like cutaneous leishmaniasis in a Libyan HIV patient</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Al-Dwibe</surname>
            <given-names>Hamida</given-names>
          </name>
          <address>
            <email>ahmadymm@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gashout</surname>
            <given-names>Aisha</given-names>
          </name>
          <address>
            <email>a-gashout@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Morogum</surname>
            <given-names>Abdu-Maged</given-names>
          </name>
          <address>
            <email>al-dwibeh@yahoo.co.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>El-Zubi</surname>
            <given-names>Said</given-names>
          </name>
          <address>
            <email>al-dwibeh@yahoo.co.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Amro</surname>
            <given-names>Ahmad</given-names>
          </name>
          <address>
            <email>aamro@pharm.alquds.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <aff id="Aff1"><label/>Faculty of Medicine, Dermatology Department, University of Tripoli, Tripoli, Libya </aff>
        <aff id="Aff2"><label/>Faculty of Medical Technology-Pathology Department, University of Tripoli, Tripoli, Libya </aff>
        <aff id="Aff3"><label/>Faculty of Pharmacy, Alquds University, Main Campus, P.O. Box 5100, Abu Dis Jerusalem, Palestine </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>29</day>
        <month>8</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>29</day>
        <month>8</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>7</volume>
      <elocation-id>401</elocation-id>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>4</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>7</day>
          <month>8</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Al-Dwibe et al.; licensee BioMed Central Ltd. 2014</copyright-statement>
        <license license-type="open-access">
          <license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Cutaneous leishmaniasis (CL) is one of the common tropical protozoal diseases caused by various <italic>Leishmania</italic> species, and transmitted by the sand-fly vectors, <italic>Phlebotomus</italic> and <italic>Lutzomyia</italic> species. Herein, we report for the first time a case of CL that presented as large eczematous plaques occurring on the dorsi of both feet in a Libyan drug addicted, alcoholic patient with HIV infection.</p>
        </sec>
        <sec>
          <title>Findings</title>
          <p>A 34&#xA0;year-old HIV-positive, alcoholic, drug addicted Libyan male presented to us with a history of a non-itchy skin lesions on the dorsi of both feet of 5-weeks duration. Systemic and topical antibiotics were given without improvement. Diagnosis of this patient was confirmed by observation of <italic>Leishmania</italic> amastigote bodies in stained slit-skin smear skin biopsy. After parenteral administration of sodium stiboglyconate (Pentostam) (20&#xA0;mg/kg/day) for 28&#xA0;days the lesions did not show any marked improvement. Concurrently, combination therapy of oral rifampicin (600&#xA0;mg/day) and isoniazide (300&#xA0;mg/day) was given for 8&#xA0;weeks. Complete healing of lesions was achieved after this treatment and skin-slit smears turned negative.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Localized cutaneous leishmaniasis should be remembered in deferential diagnosis of unresponsive contact dermatitis especially for HIV-positive patients in CL endemic areas.</p>
          <p>This patient was not responding to Pentostam therapy, which is not very common in Libya. Interestingly, combination of oral rifampicin (600&#xA0;mg/day) and isoniazide (300&#xA0;mg/day) can be a successful alternative therapy.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Cutaneous leishmaniasis</kwd>
        <kwd>Contact dermatitis</kwd>
        <kwd>HIV</kwd>
        <kwd>Sodium stiboglyconate (Pentostam)</kwd>
        <kwd>Libya</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Findings</title>
      <p>A 34&#xA0;year-old HIV-positive, alcoholic, drug addicted Libyan male presented to us with a history of non itchy skin lesions on the dorsi of both feet of 5-weeks duration. The lesions started as small non itchy papules which gradually increased in size and then ulcerated with offensive odour. The patient applied warm onion to treat the lesions, which turned painful and for that he sought medical advice. Systemic and topical antibiotics were given without improvement. The patient denied history of trauma, insect bite, unbalanced diabetes, or allergic diseases and no family history of the same illness.</p>
      <p>On examination, there were bilateral asymmetrical large well-defined erythematous ulcerated plaques with pus discharge and crusts involving the dorsal surface of both feet and left big toe. Yellowish brown discoloration of the surrounding skin and nails was noticed (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). In addition, we noticed the presence of painless crusted nodules over the anterior aspect of the right ankle joint and left cheek (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). No palpable subcutaneous nodules or regional lymph nodes were detected. The patient had a coated tongue and seborrheic dermatitis over his scalp, face and chest. KOH for <italic>Candida albicans</italic> examination was positive from tongue and negative from nails. Routine laboratory tests showed low leukocyte count (3.5&#x2009;&#xD7;&#x2009;103/ul), lymphopenia (16.6%), low platelets (132&#x2009;&#xD7;&#x2009;103/ul), CD-4&#xA0;T-cell count was lower than (15/ul), and positive serology for HIV and hepatitis C. Other routine investigations were normal including chest X-ray and ECG. Histopathological features revealed focal hyperkeratosis and focal parakeratosis. Stratum spongiosum showed intercellular oedema, local necrosis, and moderate acanthosis. Dermis showed diffuse and nodular mixed cellular infiltration with many extravasated RBCs (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). No characteristic tubercular granulomas were seen. The clinical picture was consistent with acute contact dermatitis with secondary bacterial infection. However, a 2&#xA0;mm punch biopsy and slit-skin smear was obtained from all lesions. Smears were fixed and stained with Giemsa&#x2019;s stain. <italic>Leishmania</italic> parasites were heavily seen inside and outside infected macrophages (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). Molecular identifications of the causative <italic>Leishmania</italic> species by amplifying the internal transcribed spacer1 (ITS1-PCR) [<xref ref-type="bibr" rid="CR1">1</xref>] failed due to PCR inhibition problems. After parenteral administration of sodium stiboglyconate (Pentostam) (20&#xA0;mg/kg/day) for 28&#xA0;days the lesions did not show any marked improvement, and skin-slit smears were positive for <italic>Leishmania</italic> parasites after this period. The patient was referred to the infectious department for antiretroviral therapy and further HIV care. Concurrently, combination therapy of oral Rifampicin (600&#xA0;mg/day) and Isoniazide (300&#xA0;mg/day) was given for 8&#xA0;weeks. Complete healing of lesions was achieved after this treatment and skin-slit smears turned negative (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Painless crusted nodule over left cheek at angle of mandible and bilateral asymmetrical large well-defined erythematous ulcerated plaques with crusts over dorsi of feet (left images).</bold> Complete healing after two months treatment by Rifampicin and Isoniazide (right images).</p></caption><graphic xlink:href="13071_2014_1567_Fig1_HTML" id="d30e311"/></fig><fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Intra-and extra cellular</bold>
<bold><italic>Leishmania</italic></bold>
<bold>parasites as shown in Giemsa-stained slit-skin smear (Left).</bold> Histopathological findings of lesions obtained from dorsal surface of right foot (right).</p></caption><graphic xlink:href="13071_2014_1567_Fig2_HTML" id="d30e330"/></fig></p>
      <p>Cutaneous leishmaniasis (CL) is one of the common tropical protozoal diseases caused by various <italic>Leishmania</italic> species, and transmitted by the sand-fly vector of <italic>Phlebotomus</italic> and <italic>Lutzomyia</italic> species. About 1.5 million new cases are reported each year, and over 350 million people live in areas of active parasite transmission [<xref ref-type="bibr" rid="CR2">2</xref>&#x2013;<xref ref-type="bibr" rid="CR5">5</xref>]. CL is a major public health problem in Libya caused by <italic>L. major</italic> and <italic>L. tropica</italic>
[<xref ref-type="bibr" rid="CR6">6</xref>]. <italic>Leishmania</italic> species can cause a wide spectrum of cutaneous lesions such as localized cutaneous, muco-cutaneous, diffuse cutaneous, or post-kala-azar dermal leishmaniasis [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. In HIV-positive patients: asymptomatic and mucosal leishmaniasis has been reported in addition to other usual types [<xref ref-type="bibr" rid="CR9">9</xref>]. However, HIV-positive intravenous drug users (IVDUs) can be infected with <italic>Leishmania</italic> by sharing of contaminated syringes and needles [<xref ref-type="bibr" rid="CR9">9</xref>]. Clinical variation of leishmaniasis &#x2013;HIV co-infection is determined by parasite species and host cell mediated immunity (CMI) response [<xref ref-type="bibr" rid="CR2">2</xref>]. Recently, clinical variants of CL with or without HIV co-infection have been reported such as; sporotrichoid, psoriasiform, warty, erysipeloid, impetigo like, cold cellulitis, zosteriform, acneiform, and eczematoid variant [<xref ref-type="bibr" rid="CR10">10</xref>&#x2013;<xref ref-type="bibr" rid="CR12">12</xref>]. The incidence of eczematoid variant of localized CL seems not to be very common and reported to be 2.3% [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
      <p>Herein, we report for the first time a case of Pentostam unresponsive CL that presented as large eczematous plaques occurring on the dorsi of both feet in a Libyan drug addicted patient with HIV infection. Localized CL typically presented as papules, nodules, plaques, ulcerated or crusted nodules. A contact dermatitis like morphology of localized CL lesions is unusual. Diagnosis of CL was confirmed by observation of parasites in stained slit-skin smears. This patient was unresponsive to Pentostam, which is not very common in Libya. Combination therapy of oral rifampicin and isoniazide completely cured the lesions. This combination therapy is used in Libya to treat cutaneous tuberculosis and to treat CL cases unresponsive to parenteral administration of Pentostam [<xref ref-type="bibr" rid="CR6">6</xref>]. A previous study by Peters <italic>et al.</italic>
[<xref ref-type="bibr" rid="CR13">13</xref>] descried a striking remission of CL in a Brazilian patient by using this combination. Small scale studies on oral rifampicin treatment of CL have shown a healing rate of 73.9%, 75% and 83.3% [<xref ref-type="bibr" rid="CR14">14</xref>&#x2013;<xref ref-type="bibr" rid="CR16">16</xref>] respectively. However, no clinical trial was carried out to approve combination therapy of rifampicin and isoniazide in treatment of CL [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
      <p>The patient denied insect bites though he came from Gabel Garby where CL is endemic, possibly the patient was unnoticeably bitten during drug and alcohol intake.</p>
      <p>According to ethical approval of this study, the patient agreed to publish his photos and case history anonymously. Written informed consent was obtained from the patient. The study was revised and approved by (Research Ethics committee, University of Tripoli, Libya).</p>
    </sec>
    <sec id="Sec2" sec-type="conclusions">
      <title>Conclusion</title>
      <p>The learning points from this short report is that localized cutaneous leishmaniasis should be considered in differential diagnosis of unresponsive contact dermatitis especially for HIV-positive patients in CL endemic areas. A combination of oral rifampicin (600&#xA0;mg/day) and isoniazide (300&#xA0;mg/day) can be successful alternative therapy for Pentostam unresponcive CL patients in Libya. However, this combination therapy has to be assessed at a larger scale.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>HA and AA designed the study, AG, AMM and SE investigated the patient and have done the clinical evaluation and laboratory tests. AA and HA have done the molecular experiments. HA and AA have written the manuscript. All authors read and approved the final version of the manuscript.</p>
      </fn>
    </fn-group>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schonian</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nasereddin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dinse</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Schweynoch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schallig</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Presber</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
          <article-title>PCR diagnosis and characterization of <italic>Leishmania</italic> in local and imported clinical samples</article-title>
          <source>Diagn Micr Infect Dis</source>
          <year>2003</year>
          <volume>47</volume>
          <issue>1</issue>
          <fpage>349</fpage>
          <lpage>358</lpage>
          <pub-id pub-id-type="doi">10.1016/S0732-8893(03)00093-2</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaudhary</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Bilimoria</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Katare</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>Diffuse cutaneous leishmaniasis: co-infection with human immunodeficiency virus (HIV)</article-title>
          <source>Indian J Dermatol Venereol Leprol</source>
          <year>2008</year>
          <volume>74</volume>
          <issue>6</issue>
          <fpage>641</fpage>
          <lpage>643</lpage>
          <pub-id pub-id-type="doi">10.4103/0378-6323.45111</pub-id>
          <pub-id pub-id-type="pmid">19171992</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hepburn</surname>
              <given-names>NC</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous leishmaniasis: an overview</article-title>
          <source>J Postgrad Med</source>
          <year>2003</year>
          <volume>49</volume>
          <issue>1</issue>
          <fpage>50</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="doi">10.4103/0022-3859.928</pub-id>
          <pub-id pub-id-type="pmid">12865571</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="other"><bold>WHO technical report series</bold><italic>Control of the Leishmaniases</italic> 2010. (949):xii-xiii, 1&#x2013;186, back cover</mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alvar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Velez</surname>
              <given-names>ID</given-names>
            </name>
            <name>
              <surname>Bern</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Herrero</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Desjeux</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cano</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jannin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>den Boer</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Leishmaniasis worldwide and global estimates of its incidence</article-title>
          <source>PLoS One</source>
          <year>2012</year>
          <volume>7</volume>
          <issue>5</issue>
          <fpage>e35671</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0035671</pub-id>
          <pub-id pub-id-type="pmid">22693548</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amro</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gashout</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Al-Dwibe</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zahangir Alam</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Annajar</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hamarsheh</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Shubar</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schonian</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>First molecular epidemiological study of cutaneous leishmaniasis in Libya</article-title>
          <source>PLoS NTD</source>
          <year>2012</year>
          <volume>6</volume>
          <issue>6</issue>
          <fpage>e1700</fpage>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Manzur</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Butt</surname>
              <given-names>UA</given-names>
            </name>
          </person-group>
          <article-title>Atypical cutaneous leishmaniasis resembling eczema on the foot</article-title>
          <source>Dermatol Online J</source>
          <year>2006</year>
          <volume>12</volume>
          <issue>3</issue>
          <fpage>18</fpage>
          <pub-id pub-id-type="pmid">16638432</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <mixed-citation publication-type="other"><bold>WHO publications</bold><italic>Manual for case management of cutaneous leishmaniasis in the WHO Eastern Mediterranean Region</italic> 2012, 9&#x2013;18.</mixed-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Puig</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pradinaud</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title><italic>Leishmania</italic> and HIV co-infection: dermatological manifestations</article-title>
          <source>Ann Trop Med Parasitol</source>
          <year>2003</year>
          <volume>97</volume>
          <issue>Suppl 1</issue>
          <fpage>107</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="doi">10.1179/000349803225002589</pub-id>
          <pub-id pub-id-type="pmid">14678638</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kubba</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Al-Gindan</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>el-Hassan</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Omer</surname>
              <given-names>AH</given-names>
            </name>
          </person-group>
          <article-title>Clinical diagnosis of cutaneous leishmaniasis (oriental sore)</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1987</year>
          <volume>16</volume>
          <issue>6</issue>
          <fpage>1183</fpage>
          <lpage>1189</lpage>
          <pub-id pub-id-type="doi">10.1016/S0190-9622(87)70155-8</pub-id>
          <pub-id pub-id-type="pmid">3597860</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Momeni</surname>
              <given-names>AZ</given-names>
            </name>
            <name>
              <surname>Aminjavaheri</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Clinical picture of cutaneous leishmaniasis in Isfahan</article-title>
          <source>Iran Int J Parasitol</source>
          <year>1994</year>
          <volume>33</volume>
          <issue>4</issue>
          <fpage>260</fpage>
          <lpage>265</lpage>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cabello</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Caraballo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Millan</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Leishmaniasis in the genital area</article-title>
          <source>Rev Inst Med Trop Sao Paulo</source>
          <year>2002</year>
          <volume>44</volume>
          <issue>2</issue>
          <fpage>105</fpage>
          <lpage>107</lpage>
          <pub-id pub-id-type="doi">10.1590/S0036-46652002000200009</pub-id>
          <pub-id pub-id-type="pmid">12048548</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peters</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Lainson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Leao</surname>
              <given-names>AF</given-names>
            </name>
          </person-group>
          <article-title>Potentiating action of rifampicin and isoniazid against <italic>Leishmania mexicana</italic> amazonensis</article-title>
          <source>Lancet</source>
          <year>1981</year>
          <volume>1</volume>
          <issue>8230</issue>
          <fpage>1122</fpage>
          <lpage>1124</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(81)92296-0</pub-id>
          <pub-id pub-id-type="pmid">6112485</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Even-Paz</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Weinrauch</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Livshin</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>El-On</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Greenblatt</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
          <article-title>Rifampicin treatment of cutaneous leishmaniasis</article-title>
          <source>Int J Dermatol</source>
          <year>1982</year>
          <volume>21</volume>
          <issue>2</issue>
          <fpage>110</fpage>
          <lpage>112</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-4362.1982.tb00517.x</pub-id>
          <pub-id pub-id-type="pmid">7040263</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kochar</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Aseri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>BV</given-names>
            </name>
            <name>
              <surname>Bumb</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Mehta</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Purohit</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>The role of rifampicin in the management of cutaneous leishmaniasis</article-title>
          <source>QJM</source>
          <year>2000</year>
          <volume>93</volume>
          <issue>11</issue>
          <fpage>733</fpage>
          <lpage>737</lpage>
          <pub-id pub-id-type="doi">10.1093/qjmed/93.11.733</pub-id>
          <pub-id pub-id-type="pmid">11077029</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bumb</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Mehta</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>Oral rifampicin in cases of cutaneous leishmaniasis with multiple lesions (a pilot study)</article-title>
          <source>Indian J Dermatol Venereol Leprol</source>
          <year>2002</year>
          <volume>68</volume>
          <issue>5</issue>
          <fpage>272</fpage>
          <pub-id pub-id-type="pmid">17656965</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
